Skip to main content
WCGIC 2023 Main banner
Back

Philip A. Philip, MD, PhD, FRCP

Wayne State University School of Medicine/Henry Ford Health
Detroit, United States

PHILIP AGOP. PHILIP, MD, PHD, FRCP

Professor Philip is leader of the Gastrointestinal and Neuroendocrine Multidisciplinary Team at the Henry Ford Cancer Institute in Detroit. he co-leads the Pancreatic Cancer program and is Director of the Cancer Clinical Trials. He also serves as professor of Oncology and Pharmacology at Wayne State University School of Medicine. He chairs the GI Cancers Committee at the national cooperative research group SWOG. Dr. Philip earned his medical degree at the University of Baghdad College of Medicine in Iraq and his Ph.D. in Clinical Pharmacology and Pharmacogenetics at the University of London Guy’s Hospital Medical School in the United Kingdom. He completed a fellowship in Medical Oncology at the University of Oxford and M.D. Anderson Cancer Center in Houston. He is ABIM board certified in Medical Oncology in the United States and a Fellow of the Royal College of Physicians in the United Kingdom. His major research interests are in the development of new therapies for gastrointestinal and neuroendocrine cancers with a major focus on pancreatic cancer. He has been a principal investigator on clinical trials in pancreatic and other GI cancers. Dr. Philip has authored more than 250 manuscripts, review articles and editorials and co-edited a book on pancreatic cancer. Dr Philip is a member of the scientific advisory boards of the Pancreatic Cancer Action Network and the Skyfoundation in addition to various advisory roles with pharmaceutical companies. He is a member of ASCO, AACR, and ESMO.

Presentation(s):